JP2008519848A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008519848A5 JP2008519848A5 JP2007541346A JP2007541346A JP2008519848A5 JP 2008519848 A5 JP2008519848 A5 JP 2008519848A5 JP 2007541346 A JP2007541346 A JP 2007541346A JP 2007541346 A JP2007541346 A JP 2007541346A JP 2008519848 A5 JP2008519848 A5 JP 2008519848A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition
- amino
- protecting group
- alkanoylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 41
- 239000000203 mixture Substances 0.000 claims 21
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 11
- -1 amino, monosubstituted amino Chemical group 0.000 claims 9
- 125000006239 protecting group Chemical group 0.000 claims 8
- 208000035143 Bacterial infection Diseases 0.000 claims 6
- 208000022362 bacterial infectious disease Diseases 0.000 claims 6
- 125000005236 alkanoylamino group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 125000004442 acylamino group Chemical group 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000012062 aqueous buffer Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 0 CCNC(*(C)C)=O Chemical compound CCNC(*(C)C)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62705604P | 2004-11-12 | 2004-11-12 | |
| US71070505P | 2005-08-23 | 2005-08-23 | |
| PCT/US2005/040919 WO2006110185A2 (en) | 2004-11-12 | 2005-11-11 | Antiinfective lipopeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008519848A JP2008519848A (ja) | 2008-06-12 |
| JP2008519848A5 true JP2008519848A5 (enExample) | 2008-12-25 |
Family
ID=37087468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007541346A Withdrawn JP2008519848A (ja) | 2004-11-12 | 2005-11-11 | 抗感染性リポペプチド |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1814588A2 (enExample) |
| JP (1) | JP2008519848A (enExample) |
| KR (1) | KR20070086038A (enExample) |
| AU (1) | AU2005330517A1 (enExample) |
| BR (1) | BRPI0517830A (enExample) |
| CA (1) | CA2587848A1 (enExample) |
| IL (1) | IL183109A0 (enExample) |
| NO (1) | NO20072634L (enExample) |
| RU (1) | RU2007121705A (enExample) |
| WO (1) | WO2006110185A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ594019A (en) * | 2008-12-22 | 2013-08-30 | Cubist Pharm Inc | Novel antibacterial agents for the treatment of gram positive infections |
| MX2013013760A (es) * | 2011-05-26 | 2014-01-08 | Cubist Pharm Inc | Composiciones de cb-183, 315 y metodos relacionados. |
| KR101723649B1 (ko) | 2014-10-23 | 2017-04-06 | 서울대학교산학협력단 | 신규한 펩티드 화합물, 이의 생산 방법, 및 이의 용도 |
| CN113061164B (zh) * | 2021-03-29 | 2023-01-10 | 四川大学 | 环脂肽类化合物及其在抗类风湿关节炎药物中的应用 |
| WO2023152229A1 (en) | 2022-02-09 | 2023-08-17 | Teitur Trophics Aps | Novel peptides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0017026A (pt) * | 1999-12-15 | 2003-01-07 | Cubist Pharm Inc | Lipeptìdeos como agentes antibacterianos |
| IL150224A0 (en) * | 1999-12-15 | 2002-12-01 | Cubist Pharm Inc | Lipopeptides and pharmaceutical compositions containing the same |
| CN1423656A (zh) * | 1999-12-15 | 2003-06-11 | 卡比斯特制药公司 | 作为抗菌剂的脂肽 |
| WO2003017924A2 (en) * | 2001-08-06 | 2003-03-06 | Cubist Pharmaceuticals, Inc. | Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| EP1421097A4 (en) * | 2001-08-06 | 2005-07-06 | Cubist Pharm Inc | COMPOSITIONS AND METHODS RELATING TO THE BIOSYNTHETIC MULTIGENIC FAMILY OF DAPTOMYCIN |
-
2005
- 2005-11-11 RU RU2007121705/04A patent/RU2007121705A/ru not_active Application Discontinuation
- 2005-11-11 JP JP2007541346A patent/JP2008519848A/ja not_active Withdrawn
- 2005-11-11 WO PCT/US2005/040919 patent/WO2006110185A2/en not_active Ceased
- 2005-11-11 EP EP05857738A patent/EP1814588A2/en not_active Withdrawn
- 2005-11-11 BR BRPI0517830-4A patent/BRPI0517830A/pt not_active IP Right Cessation
- 2005-11-11 AU AU2005330517A patent/AU2005330517A1/en not_active Abandoned
- 2005-11-11 KR KR1020077013150A patent/KR20070086038A/ko not_active Withdrawn
- 2005-11-11 CA CA002587848A patent/CA2587848A1/en not_active Abandoned
-
2007
- 2007-05-10 IL IL183109A patent/IL183109A0/en unknown
- 2007-05-24 NO NO20072634A patent/NO20072634L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023005983A (es) | Nuevos agentes antivirales derivados de la espiropirrolidina. | |
| JP2011528713A5 (enExample) | ||
| RU2006109467A (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| JP2007520452A5 (enExample) | ||
| JP2013525318A5 (enExample) | ||
| JP2009504763A5 (enExample) | ||
| RU2011127079A (ru) | Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с | |
| TW200600492A (en) | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication | |
| TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| JP2008534453A5 (enExample) | ||
| JP2003522198A5 (enExample) | ||
| JP2015521617A5 (enExample) | ||
| JP2022512736A5 (enExample) | ||
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| RU2450015C2 (ru) | Производные аминотиазола и их применение в качестве антибактериальных средств | |
| JP2006511446A5 (enExample) | ||
| JPWO2023054732A5 (enExample) | ||
| JP2018172383A5 (ja) | 魚介類のベコ病の経口投与用治療剤組成物及びそれを用いた魚介類のベコ病の治療方法 | |
| RU2003134629A (ru) | Соединения цефема | |
| TW200639159A (en) | Treatment of pain | |
| JP2004530699A5 (enExample) | ||
| WO2020117755A1 (en) | Compositions and methods for treating biofilms | |
| WO2024107783A3 (en) | Novel macrocyclic chalcone-amide derived antiviral agents | |
| JP2002509858A5 (enExample) | ||
| JP2005527575A5 (enExample) |